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Background: Dementia includes a group of neurodegenerative disorders characterized by progressive loss of
cognitive function and a decrease in the ability to perform activities of daily living. Systematic reviews of diagnostic
test accuracy (DTA) focus on how well the index test detects patients with the disease in terms of figures such as
sensitivity and specificity. Although DTA reviews about dementia are essential, at present there is no information
about their quantity and quality.
Methods: We searched for DTA reviews in MEDLINE (1966–2013), EMBASE (1980–2013), The Cochrane Library (from
its inception until December 2013) and the Database of Abstracts of Reviews of Effects (DARE). Two reviewers
independently assessed the methodological quality of the reviews using the AMSTAR measurement tool, and the
quality of the reporting using the PRISMA checklist. We describe the main characteristics of these reviews, including
basic characteristics, type of dementia, and diagnostic test evaluated, and we summarize the AMSTAR and PRISMA
scores.
Results: We selected 24 DTA systematic reviews. Only 10 reviews (41.6%), assessed the bias of included studies and
few (33%) used this information to report the review results or to develop their conclusions Only one review (4%)
reported all methodological items suggested by the PRISMA tool. Assessing methodology quality by means of the
AMSTAR tool, we found that six DTA reviews (25%) pooled primary data with the aid of methods that are used for
intervention reviews, such as Mantel-Haenszel and separate random-effects models (25%), while five reviews (20.8%)
assessed publication bias by means of funnel plots and/or Egger’s Test.
Conclusions: Our assessment of these DTA reviews reveals that their quality, both in terms of methodology and
reporting, is far from optimal. Assessing the quality of diagnostic evidence is fundamental to determining the
validity of the operating characteristics of the index test and its usefulness in specific settings. The development of
high quality DTA systematic reviews about dementia continues to be a challenge.
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Population ageing is generating a considerable increase in
chronic and neurodegenerative diseases, as well as severe
consequences for global public health [1,2]. Dementia in-
cludes a group of neurodegenerative disorders characte-
rized by progressive loss of cognitive function as well as* Correspondence: iarevalo@fucsalud.edu.co
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article, unless otherwise stated.the ability to perform activities of daily living, sometimes
accompanied by neuropsychiatric symptoms [3]. Criteria
for dementia diagnosis include a deficit in one or more
cognitive domains that is severe enough to impair func-
tional activities, and is progressive over a period of at least
six months and not attributable to any other brain disease
[4,5]. The presence of cognitive impairment, a fundamental
part of the dementia profile, could be detected through a
combination of history, clinical examination, and objective
cognitive assessment such as a brief mental assessment or
comprehensive neuropsychological testing [6,7]. At present,ed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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